MedTrace Logo

Umbilical Cord-derived Mesenchymal Stem Cell Injectables for the Regeneration of Partial-thickness Rotator Cuff Tears

NCT07605559 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2026-05-26

No results posted yet for this study

Summary

The purpose of this study is to evaluate umbilical cord-derived mesenchymal stem cell injectables for the regeneration of partial-thickness rotator cuff tears

Conditions

  • Rotator Cuff Disease

Interventions

BIOLOGICAL

umbilical cord-derived mesenchymal stem cell

Administration of high-dose or medium-dose umbilical cord-derived mesenchymal stem cells

DRUG

Normal Saline

Administration of normal saline as a placebo control.

Sponsors & Collaborators

  • Kyoung Hwan Koh

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-01
Primary Completion
2027-12-31
Completion
2028-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07605559 on ClinicalTrials.gov